Money Concepts Capital Corp Regenxbio Inc. Transaction History

Money Concepts Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$18.08 - $24.55 $5,695 - $7,733	315 Added 1.05%	30,245 $571,000
Q3 2022 Oct 27, 2022	BUY	$22.29 - $35.04 $656,953 - $1.03 Million	29,473 Added 4995.42%	30,063 $795,000
Q2 2022 Jul 18, 2022	SELL	$19.35 - $35.04 $793 - $1,436	-41 Reduced 6.5%	590 $15,000
Q1 2022 May 13, 2022	BUY	$24.62 - $34.31 $15,535 - $21,649	631 New	631 $21,000

192

42.6M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $590M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.